The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Illicit anabolic–androgenic steroid use
Open accessAbstract
The anabolic-androgenic steroids (AAS) are a family of hormones that includes testosterone and its derivatives. These substances have been used by elite athletes since the 1950s, but they did not become widespread drugs of abuse in the general population until the 1980s. Thus, knowledge of the medical and behavioral effects of illicit AAS use is still evolving. Surveys suggest that many millions of boys and men, primarily in Western countries, have abused AAS to enhance athletic performance or personal appearance. AAS use among girls and women is much less common. Taken in supraphysiologic doses, AAS show various long-term adverse medical effects, especially cardiovascular toxicity. Behavioral effects of AAS include hypomanic or manic symptoms, sometimes accompanied by aggression or violence, which usually occur while taking AAS, and depressive symptoms occurring during AAS withdrawal. However, these symptoms are idiosyncratic and afflict only a minority of illicit users; the mechanism of these idiosyncratic responses remains unclear. AAS users may also ingest a range of other illicit drugs, including both “body-image” drugs to enhance physical appearance or performance, and classical drugs of abuse. In particular, AAS users appear particularly prone to opioid use. There may well be a biological basis for this association, since both human and animal data suggest that AAS and opioids may share similar brain mechanisms. Finally, AAS may cause a dependence syndrome in a substantial minority of users. AAS dependence may pose a growing public health problem in future years, but remains little studied.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–209 of 209
Stanley, A. K., & Ward, M. (1994) · Medicine Science and the Law · doi:10.1177/002580249403400115 · Cited by 23
Schwartzer, J. J., Ricci, L. A., & Melloni, R. H. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.11.048 · Cited by 22
Riem, K. E., & Hursey, K. G. (1995) · Clinical Psychology Review · doi:10.1016/0272-7358(95)00013-f · Cited by 16
Testosterone in male involutional melancholia
Barahal, H. S. (1938) · Psychiatric Quarterly · doi:10.1007/bf01562836 · Cited by 14
Multiple Drug Use and Dietary Restraint in a Mr. Universe Competitor: Psychobiological Effects
Wilson-Fearon, C., & Parrott, A. C. (1999) · Perceptual and Motor Skills · doi:10.2466/pms.1999.88.2.579 · Cited by 13
USE OF TESTOSTERONE PROPIONATE IN TREATMENT OF INVOLUTIONAL PSYCHOSIS IN THE MALE
Davidoff, E. (1942) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1942.02290110131007 · Cited by 13
Massive dose testosterone therapy in male involutional psychosis
Zeifert, M. (1942) · Psychiatric Quarterly · doi:10.1007/bf01576141 · Cited by 10
(1991) · New England Journal of Medicine · doi:10.1056/nejm199106273242612 · Cited by 8
New Concepts Regarding the Relationship of Testosterone and Prostate Cancer
Morgentaler, A. (2007) · Future Oncology · doi:10.2217/14796694.3.2.123 · Cited by 5
Cited by
Sagoe, D., Molde, H., Andreassen, C. S., Torsheim, T., & Pallesen, S. (2014) · Annals of Epidemiology · doi:10.1016/j.annepidem.2014.01.009 · Cited by 686
Pope, H. G., Wood, R. I., Rogol, A., Nyberg, F., Bowers, L., & Bhasin, S. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1058 · Cited by 658
Self-citationLifestyle causes of male infertility
Durairajanayagam, D. (2018) · Arab Journal of Urology · doi:10.1016/j.aju.2017.12.004 · Cited by 411
Pope, H. G., Kanayama, G., Athey, A., Ryan, E., Hudson, J. I., & Baggish, A. (2014) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2013.12118.x · Cited by 306
Self-citationHandelsman, D. J. (2013) · Medical Journal of Australia · doi:10.5694/mja13.10111 · Cited by 253
Metadata
- Authors
- Kanayama, G., Hudson, J. I., & Pope, H. G.
- Venue
- Hormones and Behavior
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 58
- Issue
- 1
- Pages
- 111-121
- ISSN
- 0018-506X (ISSN-L)
- OpenAlex
- W2130414446
- Cited by
- 257
- References
- 209
- FWCI
- 41.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.